Clinical Trial: A Phase III Clinical Study of Jinpei Growth Hormone Injection in the Treatment of Short Stature Children With Small for Gestational Age (SGA)

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07841678) titled 'A Phase III Clinical Study of Jinpei Growth Hormone Injection in the Treatment of Short Stature Children With Small for Gestational Age (SGA)' on Sept. 20.

Brief Summary: This is a multicenter, randomized, open-label, active-controlled Phase III clinical study to evaluate the efficacy, safety and pharmacokinetic (PK) characteristics of once-weekly PEG-hGH injection compared with once-daily hGH injection in the treatment of prepubertal children with short stature due to small for gestational age (SGA) who have not received prior growth hormone treatment.

Eligible subjects will be randomized in a 2:1 ratio to receive either PEG-hGH ...